This manuscript presents the NEST to ARC Theory of Neurodivergent Grief grounded in fourteen years of doctoral level clinical practice, longitudinal observation and research synthesis across outpatient psychotherapy, crisis intervention, consultation liaison work and end of life care. Neurodivergent individuals often grieve within nervous systems shaped by chronic sensory, load executive function strain, social exclusion and cumulative trauma exposure. Across clinical settings, a reproducible pattern is observed when grief is treated using neurotypical assumptions, particularly exposure forward protocols delivered without neurodivergent titration skills, only cognitive behavioral variants that underaddress attachment and meaning, and metaphor forward narrative approaches that over rely on interpretive abstraction. Many clients demonstrate symptom escalation, functional regression, care dropout and subsequent treatment intensification. Persistent Autistic Burnout [1] is conceptualized as a load bearing moderator that narrows oscillation bandwidth, the safe capacity to move between loss oriented processing and restoration oriented functioning [2] without prolonged threat physiology. Prolonged grief is reframed as a predictable outcome of failure of fit misalignment between nervous system needs and environmental or treatment demands rather than an individual pathology. NEST Neuroception Executive scaffolding Sensory accommodation Titration restores regulatory capacity, while ARC Attachment Rituals and Rights Community and Communication restores relational inclusion legitimacy and meaning. A pragmatic differential diagnosis pathway is offered to distinguish prolonged grief disorder complex PTSD major depression and dissociation or psychosis like phenomena using measures such as PG 13 R and the International Trauma Questionnaire. A multi phase research and implementation agenda is proposed alongside ethical recommendations to reduce preventable harm.
Cite this paper
Jefferies, J. M. (2026). The Nest to Arc Theory of Neurodivergent Grief. Open Access Library Journal, 13, e15008. doi: http://dx.doi.org/10.4236/oalib.1115008.
Raymaker, D.M., Teo, A.R., Steckler, N.A., Lentz, B., Scharer, M., Delos Santos, A., et al. (2020) “Having All of Your Internal Resources Exhausted Beyond Measure and Being Left with No Clean-Up Crew”: Defining Autistic Burnout. Autism in Adult-hood, 2, 132-143. https://doi.org/10.1089/aut.2019.0079
Stroebe, M. and Schut, H. (2010) The Dual Process Mod-el of Coping with Bereavement: A Decade on. OMEGA—Journal of Death and Dying, 61, 273-289. https://doi.org/10.2190/om.61.4.b
Lord, C., Elsabbagh, M., Baird, G. and Veenstra-Vanderweele, J. (2018) Autism Spectrum Disorder. The Lancet, 392, 508-520. https://doi.org/10.1016/s0140-6736(18)31129-2
Prigerson, H.G., Boelen, P.A., Xu, J., Smith, K.V. and Maciejewski, P.K. (2021) Validation of the New DSM-5-TR Criteria for Prolonged Grief Disorder and the pg-13-Revised (pg-13-r) Scale. World Psychiatry, 20, 96-106. https://doi.org/10.1002/wps.20823
Cloitre, M., Shevlin, M., Brewin, C.R., Bisson, J.I., Roberts, N.P., Maercker, A., et al. (2018) The International Trauma Questionnaire: Development of a Self-Report Measure of ICD-11 PTSD and Complex PTSD. Acta Psychiatrica Scandinavica, 138, 536-546. https://doi.org/10.1111/acps.12956
Yoshida, K., et al. (2023) Prevalence of Psychotropic Medication Use and Psychotropic Polypharmacy in Autistic Adults with or without Intellectual Disability. Journal of Autism and Developmental Disorders, 55, 457-471.
Carthy, E., et al. (2016) Psychotropic Medication Prescribing in People with Autism Spectrum Disorders with and without Psychiatric Comorbidity. BJPsych Advances, 29, 131-140.
Lopes, L.P.N., de Oliveira, J.C., Berga-maschi, C.d.C., Fulone, I., Lima, E.d.C., Abe, F.C., et al. (2023) Use of Second-Generation Antipsychotics in Autism Spectrum Disorder: A Systematic Review and Meta-Analysis Protocol. BMJ Open, 13, e069114. https://doi.org/10.1136/bmjopen-2022-069114
McCarthy, J.M. and Chaplin, E. (2022) Adults with Intellectual Disability and Autism Spectrum Disorder: What Is the Evidence around the Use of Polypharmacy. International Journal of Environmental Research and Public Health, 19, Article No. 15974. https://doi.org/10.3390/ijerph192315974